Reporting owner
Gaslightwala Abizer
Reporting owner CIK 0002049375 · CEO · Director
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
8 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Gaslightwala Abizer | Stock award |
| Oct 14, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Gaslightwala Abizer | Exercise / conversion |
| Oct 14, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Gaslightwala Abizer | Exercise / conversion |
| Sep 29, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Gaslightwala Abizer | Stock award |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Gaslightwala Abizer | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Gaslightwala Abizer | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Gaslightwala Abizer | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Gaslightwala Abizer | Purchase |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | Stock awardStock Option (Right to Buy)Derivative security · Code A | 174,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M | 7,733 | 0.0004Value: 3.0932Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M | 19,333 | 0.0004Value: 7.7332Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 6,430 | 9.72Value: 62,499.6Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 773,323 | 0.4041 *Value: 312,499.8243Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | PurchaseWarrants to purchase ADRsDerivative security · Code P | 773,323 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 309,328 | 0.4041 *Value: 124,999.4448Currency not specified | View ↗ |
| Trade: | Akari Therapeutics PlcAKTX · company listings | Gaslightwala AbizerCEO · Director | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 309,328 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
8 transactions on this page. Filing date, newest first.